Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NCOA2 |
| Upstream (Parents) |
|---|
| (<<) ZNF780A///ZNF780B → NCOA2 |
| (<<) WASL → NCOA2 |
| (<<) SKP2 → NCOA2 |
| (<<) HNRNPH1 → NCOA2 |
| (<<) FH → NCOA2 |
| (<<) MANEA → NCOA2 |
| Downstream (Children) |
|---|
| NCOA2 → TLK1 (>>) |
| NCOA2 → NEAT1 (>>) |
| NCOA2 → EIF4EBP2 (>>) |
| NCOA2 → WWOX (>>) |
| NCOA2 → ZNF780A///ZNF780B (>>) |
| NCOA2 → TLE4 (>>) |
| NCOA2 → SLC5A3 (>>) |
| NCOA2 → NEK9 (>>) |
| NCOA2 → OBP2A///OBP2B (>>) |
| NCOA2 → TRIM23 (>>) |
| NCOA2 → THSD4 (>>) |
| NCOA2 → WASL (>>) |
| NCOA2 → VPS13B (>>) |
| NCOA2 → MAPK14 (>>) |
| NCOA2 → SKP2 (>>) |
| NCOA2 → HNRNPH1 (>>) |
| NCOA2 → F11R (>>) |
| NCOA2 → MCL1 (>>) |
| NCOA2 → ATP13A3 (>>) |
| NCOA2 → MBNL2 (>>) |
| NCOA2 → MANEA (>>) |
| NCOA2 → UTP18 (>>) |
| NCOA2 → EIF4G2 (>>) |
| NCOA2 → PPP2CB (>>) |
